Literature DB >> 29621057

Controlling for Frailty in Pharmacoepidemiologic Studies of Older Adults: Validation of an Existing Medicare Claims-based Algorithm.

Carmen C Cuthbertson1, Anna Kucharska-Newton1, Keturah R Faurot1, Til Stürmer1, Michele Jonsson Funk1, Priya Palta1, B Gwen Windham2, Sydney Thai1, Jennifer L Lund1.   

Abstract

BACKGROUND: Frailty is a geriatric syndrome characterized by weakness and weight loss and is associated with adverse health outcomes. It is often an unmeasured confounder in pharmacoepidemiologic and comparative effectiveness studies using administrative claims data.
METHODS: Among the Atherosclerosis Risk in Communities (ARIC) Study Visit 5 participants (2011-2013; n = 3,146), we conducted a validation study to compare a Medicare claims-based algorithm of dependency in activities of daily living (or dependency) developed as a proxy for frailty with a reference standard measure of phenotypic frailty. We applied the algorithm to the ARIC participants' claims data to generate a predicted probability of dependency. Using the claims-based algorithm, we estimated the C-statistic for predicting phenotypic frailty. We further categorized participants by their predicted probability of dependency (<5%, 5% to <20%, and ≥20%) and estimated associations with difficulties in physical abilities, falls, and mortality.
RESULTS: The claims-based algorithm showed good discrimination of phenotypic frailty (C-statistic = 0.71; 95% confidence interval [CI] = 0.67, 0.74). Participants classified with a high predicted probability of dependency (≥20%) had higher prevalence of falls and difficulty in physical ability, and a greater risk of 1-year all-cause mortality (hazard ratio = 5.7 [95% CI = 2.5, 13]) than participants classified with a low predicted probability (<5%). Sensitivity and specificity varied across predicted probability of dependency thresholds.
CONCLUSIONS: The Medicare claims-based algorithm showed good discrimination of phenotypic frailty and high predictive ability with adverse health outcomes. This algorithm can be used in future Medicare claims analyses to reduce confounding by frailty and improve study validity.

Entities:  

Mesh:

Year:  2018        PMID: 29621057      PMCID: PMC5980766          DOI: 10.1097/EDE.0000000000000833

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  25 in total

1.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

Authors:  S KATZ; A B FORD; R W MOSKOWITZ; B A JACKSON; M W JAFFE
Journal:  JAMA       Date:  1963-09-21       Impact factor: 56.272

Review 2.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care.

Authors:  Linda P Fried; Luigi Ferrucci; Jonathan Darer; Jeff D Williamson; Gerard Anderson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-03       Impact factor: 6.053

3.  Selective prescribing led to overestimation of the benefits of lipid-lowering drugs.

Authors:  Robert J Glynn; Sebastian Schneeweiss; Philip S Wang; Raia Levin; Jerry Avorn
Journal:  J Clin Epidemiol       Date:  2006-05-26       Impact factor: 6.437

4.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

5.  A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes.

Authors:  Amy J Davidoff; Ilene H Zuckerman; Naimish Pandya; Franklin Hendrick; Xuehua Ke; Arti Hurria; Stuart M Lichtman; Arif Hussain; Jonathan P Weiner; Martin J Edelman
Journal:  J Geriatr Oncol       Date:  2013-04       Impact factor: 3.599

6.  Development of a Claims-based Frailty Indicator Anchored to a Well-established Frailty Phenotype.

Authors:  Jodi B Segal; Hsien-Yen Chang; Yu Du; Jeremy D Walston; Michelle C Carlson; Ravi Varadhan
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

7.  Frailty consensus: a call to action.

Authors:  John E Morley; Bruno Vellas; G Abellan van Kan; Stefan D Anker; Juergen M Bauer; Roberto Bernabei; Matteo Cesari; W C Chumlea; Wolfram Doehner; Jonathan Evans; Linda P Fried; Jack M Guralnik; Paul R Katz; Theodore K Malmstrom; Roger J McCarter; Luis M Gutierrez Robledo; Ken Rockwood; Stephan von Haehling; Maurits F Vandewoude; Jeremy Walston
Journal:  J Am Med Dir Assoc       Date:  2013-06       Impact factor: 4.669

8.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

9.  Validation and comparison of two frailty indexes: The MOBILIZE Boston Study.

Authors:  Dan K Kiely; L Adrienne Cupples; Lewis A Lipsitz
Journal:  J Am Geriatr Soc       Date:  2009-07-21       Impact factor: 5.562

10.  Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic.

Authors:  Michael L Jackson; Onchee Yu; Jennifer C Nelson; Allison Naleway; Edward A Belongia; Roger Baxter; Komal Narwaney; Steven J Jacobsen; David K Shay; Lisa A Jackson
Journal:  Am J Epidemiol       Date:  2013-08-26       Impact factor: 4.897

View more
  18 in total

1.  Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice.

Authors:  Aaron P Mitchell; Alan C Kinlaw; Sharon Peacock-Hinton; Stacie B Dusetzina; Hanna K Sanoff; Jennifer L Lund
Journal:  Oncologist       Date:  2019-10-14

2.  Measuring Frailty in Administrative Claims Data: Comparative Performance of Four Claims-Based Frailty Measures in the U.S. Medicare Data.

Authors:  Dae Hyun Kim; Elisabetta Patorno; Ajinkya Pawar; Hemin Lee; Sebastian Schneeweiss; Robert J Glynn
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-05-22       Impact factor: 6.053

3.  Geriatric oncology health services research: Cancer and Aging Research Group infrastructure core.

Authors:  Melisa L Wong; Stuart M Lichtman; Gary R Morrow; John Simmons; Tomma Hargraves; Cary P Gross; Jennifer L Lund; Lisa M Lowenstein; Louise C Walter; Cara L McDermott; Supriya G Mohile; Harvey Jay Cohen
Journal:  J Geriatr Oncol       Date:  2019-07-17       Impact factor: 3.599

4.  Identifying Data Elements to Measure Frailty in a Dutch Nationwide Electronic Medical Record Database for Use in Postmarketing Safety Evaluation: An Exploratory Study.

Authors:  Janet Sultana; Ingrid Leal; Marcel de Wilde; Maria de Ridder; Johan van der Lei; Miriam Sturkenboom; Gianluca Trifiro'
Journal:  Drug Saf       Date:  2019-06       Impact factor: 5.606

5.  Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis.

Authors:  Anne M Butler; J Bradley Layton; Vikas R Dharnidharka; John M Sahrmann; Marissa J Seamans; David J Weber; Leah J McGrath
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

6.  Evaluation of Frailty as an Unmeasured Confounder in Observational Studies of Antidiabetic Medications.

Authors:  Caroline A Presley; Jonathan Chipman; Jea Young Min; Carlos G Grijalva; Robert A Greevy; Marie R Griffin; Christianne L Roumie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-07-12       Impact factor: 6.053

7.  A Warning About Using Predicted Values From Regression Models for Epidemiologic Inquiry.

Authors:  Elizabeth L Ogburn; Kara E Rudolph; Rachel Morello-Frosch; Amber Khan; Joan A Casey
Journal:  Am J Epidemiol       Date:  2021-06-01       Impact factor: 4.897

8.  Effects of anticholinergic and sedative medication use on fractures: A self-controlled design study.

Authors:  Shahar Shmuel; Virginia Pate; Marc J Pepin; Janine C Bailey; Yvonne M Golightly; Laura C Hanson; Til Stürmer; Rebecca B Naumann; Danijela Gnjidic; Jennifer L Lund
Journal:  J Am Geriatr Soc       Date:  2021-07-22       Impact factor: 5.562

9.  Propensity Score Weighting and Trimming Strategies for Reducing Variance and Bias of Treatment Effect Estimates: A Simulation Study.

Authors:  Til Stürmer; Michael Webster-Clark; Jennifer L Lund; Richard Wyss; Alan R Ellis; Mark Lunt; Kenneth J Rothman; Robert J Glynn
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

10.  Quantifying cumulative anticholinergic and sedative drug load among US Medicare Beneficiaries.

Authors:  Shahar Shmuel; Virginia Pate; Marc J Pepin; Janine C Bailey; Laura C Hanson; Til Stürmer; Rebecca B Naumann; Yvonne M Golightly; Danijela Gnjidic; Jennifer L Lund
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-10-15       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.